People with
both HIV and Hepatitis C (HCV) face much more danger of death than
those with HIV alone, the autumn BHIVA conference heard.
Dr Mark Nelson, of the Chelsea and Westminster Hospital, said that
HIV/HCV co-infection was now such a serious problem that 50 per
cent of deaths on Aids wards were now due to liver failure.
“In the past we told our patients: ‘Don’t worry
because you’re going to die from HIV, not Hepatitis’
but now HCV is much more aggressive in the HIV population and the
disease progression rate is very fast.”
The high rates of HIV/HCV co-infection are not just among intravenous
drug users but also among gay men, where they are now as high as
14 per cent, and among infants of co-infected mothers the rate is
as much as 17 per cent, Dr Nelson said.
Hepatitis C has now been shown to be transmitted sexually and Dr
Nelson said that he has seen 24 new cases this year at his clinic,
often at the same time as HIV and syphilis infections.
With the advent of new drugs, especially pegylated interferon and
ribavirin, HCV is now “potentially a treatable disease.”
However, the results of HCV treatments are often disappointing and
only work in less than half of co-infected patients.
He suggested that all patients at HIV clinics should be regularly
screened for HCV and all people need to be made aware that HCV can
be transmitted sexually.
“It’s important to treat each patient as a person, not
as a lump of meat,” Dr Nelson added.
Martin Flynn
|
viruses,
could potentially be used as a strategy for treating HIV, scientists
report.
Dr Judy Lieberman, of the Centre for Blood Research in Boston, USA,
said that RNA |
|